Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The approval followed positive Phase III OASIS trial results and was formally announced shortly thereafter
Prevention is always the more efficient path
Those claims are supported by growing adverse event data, mechanistic plausibility, and a developing body of peer-reviewed literature that we think will get us past Daubert
Glucagonlike peptide-1 relaxes rat conduit arteries via an endotheliumindependent mechanism
Pfizer's peptide-relevant pipeline includes oncology antibody-drug conjugates (which utilise peptide linker chemistry) and its manufacturing expertise in complex molecule synthesis gives it infrastructure that could support future peptide manufacturing partnerships or in-licensing opportunities
US$ 27.78
US$ 21.38
US$ 26.92
